Average Co-Inventor Count = 3.78
ph-index = 20
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pharmacyclics, Inc. (39 from 193 patents)
2. The University of Texas System (24 from 5,469 patents)
3. Other (2 from 832,880 patents)
4. Board of Regents, University of Tx (1 from 1 patent)
54 patents:
1. 10105552 - Formulations of histone deacetylase inhibitor and uses thereof
2. 10016435 - Use of inhibitors of Bruton's tyrosine kinase (Btk)
3. 10004745 - Use of inhibitors of Bruton'S tyrosine kinase (Btk)
4. 10004746 - Use of inhibitors of Bruton's tyrosine kinase (Btk)
5. 9862722 - Inhibitors of Bruton's tyrosine kinase
6. 9814721 - Use of inhibitors of bruton's tyrosine kinase (BTK)
7. 9801881 - Use of inhibitors of bruton's tyrosine kinase (BTK)
8. 9801883 - Use of inhibitors of bruton's tyrosine kinase (Btk)
9. 9717731 - TEC family kinase inhibitor adjuvant therapy
10. 9492423 - Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
11. 9403032 - Formulations of histone deacetylase inhibitor and uses therof
12. 9138436 - Inhibitors of Bruton's tyrosine kinase
13. 9133134 - Inhibitors of bruton's tyrosine kinase
14. 9125889 - Use of inhibitors of Bruton's tyrosine kinase (Btk)
15. 9012463 - Inhibitors of bruton's tyrosine kinase